Treatment of Pseudomonas putida Urinary Tract Infection After Initial Macrobid Treatment
For a patient with a urinary tract infection growing Pseudomonas putida after initial treatment with Macrobid (nitrofurantoin), treatment should be changed to a fluoroquinolone (such as ciprofloxacin) or an aminoglycoside based on susceptibility testing. 1, 2
Understanding the Clinical Scenario
- Nitrofurantoin (Macrobid) is not effective against Pseudomonas species, explaining the persistence of infection 1
- Pseudomonas putida is a gram-negative bacterium typically found in water and soil environments that can cause urinary tract infections, particularly in immunocompromised hosts 3, 4
- The initial lack of urine culture before starting treatment led to inappropriate antibiotic selection 1
Recommended Management Approach
Step 1: Obtain Proper Cultures
- Collect a urine culture and susceptibility testing to guide targeted therapy 1
- Obtain blood cultures if the patient has systemic symptoms (fever, chills, hypotension) to rule out bacteremia 2
Step 2: Select Appropriate Antimicrobial Therapy
For uncomplicated UTI with Pseudomonas putida:
For complicated UTI with systemic symptoms:
Step 3: Adjust Based on Susceptibility Results
- Modify therapy according to antimicrobial susceptibility testing 1
- For multidrug-resistant strains, consider carbapenems (meropenem or imipenem) 4, 6
Special Considerations
Duration of therapy:
Assess for complicating factors that may require longer treatment:
Follow-up Recommendations
- Repeat urine culture 1-2 weeks after completing therapy to confirm eradication 1
- If symptoms persist despite appropriate therapy, evaluate for:
Common Pitfalls to Avoid
- Continuing nitrofurantoin (Macrobid) despite Pseudomonas isolation (ineffective against this organism) 1
- Failing to obtain susceptibility testing before changing antibiotics 1
- Inadequate treatment duration, especially in complicated cases 1
- Overlooking potential sources of reinfection (catheters, stents) 1, 3